Clin2
NCT06857487Possibly a fitRecruiting

Testing an herb formula to prevent early stroke worsening

Acute Ischemic Stroke

Part of Brain & nervous system, Heart & circulation clinical trials.

This study tests a traditional Chinese herb formula called Qingre Huatan to see if it can stop stroke symptoms from getting worse in the first few days. It is for people who have had an ischemic stroke within the last 48 hours and are at high risk for early decline.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
72 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You had a stroke from a blocked blood vessel in the brain (ischemic stroke) and are in the hospital.
  • You meet the Traditional Chinese Medicine criteria for 'phlegm-heat' syndrome.
  • You are at high risk for early worsening, meaning an MRI shows new damage, you have a low ASPECTS score, or you have at least two risk factors.
  • Your stroke started within the last 48 hours.
  • You are between 18 and 80 years old.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07205328Recruiting· Phase 2
Testing MT200605 for acute ischemic stroke

This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.

Beijing, Beijing Municipality
NCT05686642Recruiting· Phase 2
Drug LT3001 for sudden stroke symptoms within 24 hours

This Phase 2 study tests LT3001 to improve recovery after an acute ischemic stroke (a stroke caused by blocked blood flow). It is designed for people who can be treated within 24 hours of symptom onset and who meet specific safety and health requirements.

Beijing, Beijing Municipality
NCT06883110Recruiting
Testing traditional Chinese medicine for recent stroke

This trial tests whether a traditional Chinese medicine (Angong Niuhuang pill) made from different sources of a natural ingredient can help people who recently had a moderate stroke caused by a blood clot. It aims to see if the pill can improve recovery.

Wuhan, Hubei
NCT07163702Not yet recruiting· Phase 2
Xinglou Chengqi Granule for recent ischemic stroke

This study tests a traditional Chinese medicine granule called Xinglou Chengqi. It is for people who had an ischemic stroke (blocked blood vessel in the brain) within the last 7 days and have certain symptoms. The goal is to see if it helps recovery and is safe.

Richmond, British Columbia
NCT07445581Not yet recruiting
Herbal medicine for elderly heart attack patients with brain artery narrowing

This study tests a traditional Chinese herbal medicine, Tanhuo Decoction, in elderly patients who have had a recent heart attack and also have narrowed brain arteries. It aims to see if adding this herbal treatment to standard care helps improve their recovery.

Beijing, Beijing Municipality
NCT06157502Recruiting· Phase 3
Shuxuening with clot-busting treatment for ischemic stroke

This trial tests if adding the herbal injection Shuxuening to standard clot-busting treatment improves recovery for people having an ischemic stroke. It is for adults within 6 hours of symptom onset who are already receiving a clot-dissolving medication.

Beijing, Beijing Municipality

Hear when a new Acute Ischemic Stroke trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.